Lack of laboratory assessment of severe hyponatraemia is associated with detrimental clinical outcomes in hospitalised patients

International Journal of Clinical Practice

Volumn 63, Issue 10, 2009, Pages 1451-1455

  Whyte, M ^a   Down, C ^a   Miell, J ^a   Crook, M ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM ION;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HYPONATREMIA; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; URINE OSMOLALITY; CASE CONTROL STUDY; DIAGNOSTIC PROCEDURE; HOSPITALIZATION; OSMOLARITY; PATIENT REFERRAL; PUBLIC HOSPITAL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CASE-CONTROL STUDIES; CLINICAL LABORATORY TECHNIQUES; FEMALE; HOSPITALIZATION; HOSPITALS, DISTRICT; HUMANS; HYPONATREMIA; MALE; OSMOLAR CONCENTRATION; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 70349260635     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02037.x     Document Type: Article

References (19)

1. Flear CT, Gill GV, Burn J. Hyponatraemia: mechanisms and management. Lancet 1981 2 : 26 31.
2. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 1986 314 : 1529 1535.
3. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986 81 : 1033 1040.
4. Kumar S, Berl T. Sodium. Lancet 1998 352 : 220 228.
5. Gill G, Huda B, Boyd A et al. Characteristics and mortality of severe hyponatraemia - a hospital-based study. Clin Endocrinol (Oxf) 2006 65 : 246 249.
6. Huda MS, Boyd A, Skagen K et al. Investigation and management of severe hyponatraemia in a hospital setting. Postgrad Med J 2006 82 : 216 219.
7. Smith DM, McKenna K, Thompson CJ. Hyponatraemia. Clin Endocrinol (Oxf) 2000 52 : 667 678.
8. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990 9 : 811 818.
9. Crook M. The investigation and management of severe hyponatraemia. J Clin Pathol 2002 55 : 883.
10. Saeed BO, Beaumont D, Handley GH, Weaver JU. Severe hyponatraemia: investigation and management in a district general hospital. J Clin Pathol 2002 55 : 893 896.
11. Khromova V, Gray TA. Learning needs in clinical biochemistry for doctors in foundation years. Ann Clin Biochem 2008 45 (Pt 1 33 8.
12. Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ 2002 166 : 1056 1062.
13. Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987 83 : 905 908.
14. Hoorn EJ, Halperin ML, Zietse R. Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. QJM 2005 98 : 529 540.
15. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967 42 : 790 806.
16. Lane N, Allen K. Hyponatraemia after orthopaedic surgery. BMJ 1999 318 : 1363 1364.
17. Arieff AI, Kozniewska E, Roberts TP, Vexler ZS, Ayus JC, Kucharczyk J. Age, gender, and vasopressin affect survival and brain adaptation in rats with metabolic encephalopathy. Am J Physiol 1995 268 (5 Pt 2 R1143 52.
18. Verbalis JG, Drutarosky MD. Adaptation to chronic hypoosmolality in rats. Kidney Int 1988 34 : 351 360.
19. Schrier RW, Gross P, Gheorghiade M et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006 355 : 2099 2112.